Price movement over the last 24 hours
Align Technology, Inc. vs Nike Inc — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Nike Inc trades at $44.44 (market cap $65.71B). The key difference: Nike Inc is far larger — about 5.1× Align Technology, Inc.'s market cap, and Nike Inc pays a 3.7% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | NKE | |
|---|---|---|
Market Cap | $12.86B | $65.71B |
Sector | Health | Consumer Cyclical |
52-Week High | $207.19 | $79.24 |
52-Week Low | $124.88 | $40.75 |
Enterprise Value | $11.92B | $67.71B |
Volume | — | 8,887,180 |
Dividend Yield | — | 3.7% |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Nike (NKE) trades at $44.37, up 3.72% today, with a bearish technical signal but strong profitability metrics including a 22.14% ROE. Recent earnings have consistently beaten estimates, though revenue declined to $46.31B in 2025. The stock faces headwinds from inventory challenges and softer demand in key markets like China, yet maintains a dominant brand position and analyst consensus price target of $50.67.
The outlook hinges on Nike's turnaround strategy stabilizing earnings amid competitive pressures. Investment opportunity lies in brand strength and digital growth, but risks include margin compression and macroeconomic sensitivity. Wall Street sentiment is mixed with 48.57% buy ratings, reflecting cautious optimism for execution.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.
Read more on NKE →